Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure SystemPRNewsWire • 08/15/24
Down -14.6% in 4 Weeks, Here's Why Haemonetics (HAE) Looks Ripe for a TurnaroundZacks Investment Research • 08/09/24
Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations WebsitePRNewsWire • 08/08/24
Wall Street Analysts See a 30.13% Upside in Haemonetics (HAE): Can the Stock Really Move This High?Zacks Investment Research • 08/07/24
Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure GuidewirePRNewsWire • 07/30/24
Wall Street Analysts Think Haemonetics (HAE) Could Surge 33.2%: Read This Before Placing a BetZacks Investment Research • 07/10/24
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024PRNewsWire • 07/08/24
Haemonetics (HAE) Loses -5.16% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 06/27/24
Haemonetics Launches Limited Market Release for New VASCADE MVP XL Vascular Closure DevicePRNewsWire • 06/18/24
Don't Overlook These Highly Ranked Medical Stocks as Markets RiseZacks Investment Research • 06/12/24